These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 35033108)

  • 21. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
    Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
    J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.
    Darrah PA; Bolton DL; Lackner AA; Kaushal D; Aye PP; Mehra S; Blanchard JL; Didier PJ; Roy CJ; Rao SS; Hokey DA; Scanga CA; Sizemore DR; Sadoff JC; Roederer M; Seder RA
    J Immunol; 2014 Aug; 193(4):1799-811. PubMed ID: 25024382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Irvine EB; O'Neil A; Darrah PA; Shin S; Choudhary A; Li W; Honnen W; Mehra S; Kaushal D; Gideon HP; Flynn JL; Roederer M; Seder RA; Pinter A; Fortune S; Alter G
    Nat Immunol; 2021 Dec; 22(12):1515-1523. PubMed ID: 34811542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
    Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
    Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG Vaccination Induces
    Abate G; Hamzabegovic F; Eickhoff CS; Hoft DF
    Front Immunol; 2019; 10():234. PubMed ID: 30837992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8
    Moliva JI; Hossfeld AP; Canan CH; Dwivedi V; Wewers MD; Beamer G; Turner J; Torrelles JB
    Mucosal Immunol; 2018 May; 11(3):968-978. PubMed ID: 28930287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After
    Ning H; Wang L; Zhou J; Lu Y; Kang J; Ding T; Shen L; Xu Z; Bai Y
    Front Immunol; 2019; 10():1519. PubMed ID: 31333655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis.
    Kumar S; Bhaskar A; Patnaik G; Sharma C; Singh DK; Kaushik SR; Chaturvedi S; Das G; Dwivedi VP
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33444288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells.
    Prabowo SA; Zelmer A; Stockdale L; Ojha U; Smith SG; Seifert K; Fletcher HA
    Sci Rep; 2019 Mar; 9(1):4842. PubMed ID: 30890730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety and efficacy of BCG encapsulated alginate particle (BEAP) against M.tb H37Rv infection in Macaca mulatta : A pilot study.
    Kesarwani A; Sahu P; Jain K; Sinha P; Mohan KV; Nagpal PS; Singh S; Zaidi R; Nagarajan P; Upadhyay P
    Sci Rep; 2021 Feb; 11(1):3049. PubMed ID: 33542363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.
    Platteel ACM; Nieuwenhuizen NE; Domaszewska T; Schürer S; Zedler U; Brinkmann V; Sijts AJAM; Kaufmann SHE
    Front Immunol; 2017; 8():1744. PubMed ID: 29312295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
    PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal immune responses of Mycobacterium-specific γδ T cells in tuberculous and non-tuberculous tissues during M. tuberculosis infection.
    Huang D; Chen CY; Zhang M; Qiu L; Shen Y; Du G; Zhou K; Wang R; Chen ZW
    PLoS One; 2012; 7(2):e30631. PubMed ID: 22319574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.
    Nagpal PS; Kesarwani A; Sahu P; Upadhyay P
    BMC Infect Dis; 2019 Jul; 19(1):568. PubMed ID: 31262260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
    Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
    PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis.
    Chesson CB; Huante M; Nusbaum RJ; Walker AG; Clover TM; Chinnaswamy J; Endsley JJ; Rudra JS
    Sci Rep; 2018 Aug; 8(1):12519. PubMed ID: 30131591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
    Poyntz HC; Stylianou E; Griffiths KL; Marsay L; Checkley AM; McShane H
    Tuberculosis (Edinb); 2014 May; 94(3):226-37. PubMed ID: 24572168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.